India detected 32,981 new COVID-19 cases in the last 24 hours, taking the total number of active coronavirus cases in the country to 3,96,729, Union Ministry of Health and Family Welfare informed on Monday. With 39,109 new recoveries, the number of overall recovered COVID-19 patients stand at 91,39,901, pushing the recovery rate to 94.37 per cent today.
The overall COVID-19 cases reached 96,77,203, including 3,96,729 active cases and 91,39,901 recoveries. With 391 new deaths, the cumulative toll mounted to 1,40,573.
ALSO READ | Section 144 imposed in Noida till January 2 amid COVID-19 surge
India's active Covid-19 cases below 4 lakh
- Active cases below 4 lakh after falling for 10 straight days
- Active cases fall by 6,519 to lowest level since July 20
- Last 24 hours saw testing of 8.01 lakh vs previous day’s 11.01 lakh
- Single-day testing of 8.01 lakh is at lowest level in 15 days
- Rise in deaths over last 24 hours below 400 for 1st time since June; they’re at 391
- Additions to total cases less than recoveries for 10th straight day
- Last 24 hours saw an addition of 32,981 vs recoveries of 39,109
- Recovery rate near 94%, it’s at 94.45% vs yesterday’s 94.37%
- Death rate remains at 1.45% for 8th consecutive day
- Total cases at 96.77 lakh, active 3.96 lakh, recoveries 91.39 lakh and deaths 1.40 lakh
Coronavirus cases in India |
|||||||
---|---|---|---|---|---|---|---|
S. No. |
Name of State / UT |
Active Cases* |
Cured/Discharged/Migrated* |
Deaths** |
|||
Total |
Change since yesterday |
Cumulative |
Change since yesterday |
Cumulative |
Change since yesterday |
||
1 |
Andaman and Nicobar Islands |
73 |
3 |
4624 |
8 |
61 |
|
2 |
Andhra Pradesh |
5910 |
256 |
859029 |
914 |
7033 |
9 |
3 |
Arunachal Pradesh |
735 |
13 |
15605 |
24 |
55 |
|
4 |
Assam |
3552 |
9 |
209214 |
84 |
993 |
4 |
5 |
Bihar |
5563 |
67 |
231248 |
618 |
1295 |
3 |
6 |
Chandigarh |
922 |
39 |
16814 |
60 |
291 |
2 |
7 |
Chhattisgarh |
20048 |
515 |
223772 |
702 |
2989 |
12 |
8 |
Dadra and Nagar Haveli and Daman and Diu |
14 |
1 |
3326 |
2 |
||
9 |
Delhi |
24693 |
1985 |
557914 |
4622 |
9643 |
69 |
10 |
Goa |
1364 |
20 |
46624 |
131 |
698 |
1 |
11 |
Gujarat |
14695 |
47 |
200012 |
1485 |
4081 |
17 |
12 |
Haryana |
12897 |
413 |
228411 |
1887 |
2588 |
24 |
13 |
Himachal Pradesh |
8269 |
22 |
35957 |
520 |
732 |
11 |
14 |
Jammu and Kashmir |
5170 |
161 |
106372 |
366 |
1746 |
4 |
15 |
Jharkhand |
1796 |
49 |
107496 |
134 |
986 |
7 |
16 |
Karnataka |
25400 |
422 |
855750 |
889 |
11856 |
10 |
17 |
Kerala |
61063 |
468 |
572911 |
5217 |
2418 |
28 |
18 |
Ladakh |
856 |
28 |
7917 |
81 |
120 |
|
19 |
Madhya Pradesh |
13391 |
141 |
197777 |
1585 |
3337 |
11 |
20 |
Maharashtra |
81162 |
2769 |
1723370 |
7486 |
47734 |
40 |
21 |
Manipur |
2919 |
16 |
22848 |
193 |
306 |
7 |
22 |
Meghalaya |
664 |
10 |
11453 |
61 |
120 |
2 |
23 |
Mizoram |
202 |
18 |
3728 |
20 |
6 |
|
24 |
Nagaland |
547 |
33 |
10766 |
5 |
66 |
1 |
25 |
Odisha |
3585 |
183 |
315840 |
570 |
1771 |
6 |
26 |
Puducherry |
372 |
47 |
36238 |
62 |
614 |
|
27 |
Punjab |
7896 |
169 |
143414 |
623 |
4916 |
10 |
28 |
Rajasthan |
22427 |
749 |
255729 |
2818 |
2429 |
20 |
29 |
Sikkim |
387 |
20 |
4695 |
9 |
115 |
|
30 |
Tamil Nadu |
10688 |
194 |
767759 |
1498 |
11793 |
16 |
31 |
Telengana |
7778 |
347 |
264606 |
862 |
1474 |
2 |
32 |
Tripura |
414 |
37 |
32110 |
42 |
373 |
1 |
33 |
Uttarakhand |
5223 |
47 |
71489 |
373 |
1285 |
4 |
34 |
Uttar Pradesh |
22160 |
85 |
524860 |
1993 |
7924 |
24 |
35 |
West Bengal |
23894 |
70 |
470223 |
3167 |
8723 |
46 |
Total# |
396729 |
6519 |
9139901 |
39109 |
140573 |
391 |
|
*(Including foreign Nationals) |
|||||||
**( more than 70% cases due to comorbidities ) |
|||||||
#States wise distribution is subject to further verification and reconciliation |
|||||||
#Our figures are being reconciled with ICMR |
Meanwhile, the serum Institute of India Sunday became the first indigenous company to seek emergency use authorization for its Oxford Covid-19 vaccine candidate, Covishield. The pune-based institute in collaboration with ICMR is conducting its phase-3 trials of the Oxford-AstraZeneca candidate. This comes a day after US pharmaceutical giant, Pfizer asked for an emergency use of its vaccine candidate.
ALSO MORE | Serum Institute seeks emergency use nod for Covishield in India